Correlation Between Instil Bio and Capricor Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Instil Bio and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Instil Bio and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Instil Bio and Capricor Therapeutics, you can compare the effects of market volatilities on Instil Bio and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Instil Bio with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Instil Bio and Capricor Therapeutics.

Diversification Opportunities for Instil Bio and Capricor Therapeutics

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Instil and Capricor is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Instil Bio and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and Instil Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Instil Bio are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of Instil Bio i.e., Instil Bio and Capricor Therapeutics go up and down completely randomly.

Pair Corralation between Instil Bio and Capricor Therapeutics

Considering the 90-day investment horizon Instil Bio is expected to under-perform the Capricor Therapeutics. In addition to that, Instil Bio is 1.65 times more volatile than Capricor Therapeutics. It trades about -0.18 of its total potential returns per unit of risk. Capricor Therapeutics is currently generating about -0.11 per unit of volatility. If you would invest  2,146  in Capricor Therapeutics on August 29, 2024 and sell it today you would lose (240.00) from holding Capricor Therapeutics or give up 11.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Instil Bio  vs.  Capricor Therapeutics

 Performance 
       Timeline  
Instil Bio 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Instil Bio are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite weak forward indicators, Instil Bio disclosed solid returns over the last few months and may actually be approaching a breakup point.
Capricor Therapeutics 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Capricor Therapeutics are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Capricor Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Instil Bio and Capricor Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Instil Bio and Capricor Therapeutics

The main advantage of trading using opposite Instil Bio and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Instil Bio position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.
The idea behind Instil Bio and Capricor Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios